2 ASX ETFs I'd buy for dividend income

These diversified portfolios could provide an attractive and growing source of income.

| More on:
ETF written on cubes sitting on piles of coins.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • There aren’t too many ASX ETFs then can provide a mixture of dividends and growth, but the two below could do it
  • Betashares FTSE 100 ETF is invested in 100 of the largest businesses listed in the UK
  • Australian Ex-20 Portfolio Diversifier ETF excludes the largest 20 ASX shares and is invested in the next 180

The ASX exchange-traded fund (ETF) sector of the share market can be a fruitful place to find opportunities for diversification, dividend income and growth.

Some ETFs are known for being more growth-focused, such as the iShares S&P 500 ETF (ASX: IVV) or the Vanguard Diversified High Growth Index ETF (ASX: VDHG).

I don't mind the ETFs that are focused on the large ASX shares, such as Vanguard Australian Shares Index ETF (ASX: VAS) or the BetaShares Australia 200 ETF (ASX: A200). But I don't think they have a lot of growth potential because of the nature of large ASX bank shares and large ASX mining shares.

There are a group of ASX ETFs that could provide a mixture of solid dividend income and decent capital growth. Here I'm going to tell you about two of them.

Betashares FTSE 100 ETF (ASX: F100)

The idea behind this ETF is that it tracks an index of 100 of the largest businesses that are trading on the London Stock Exchange.

While the ASX is heavily weighted to resources and banks, the F100 ETF has a more healthy split between the different sectors in my opinion. There are currently six sectors with a weighting of more than 10%: consumer staples (19.2%), financials (17.6%), energy (13.1%), healthcare (12.4%), materials (10.7%) and industrials (10.3%).

Investors may recognise some of the biggest 10 positions in the portfolio of AstraZeneca, Shell, HSBC, Unilever, BP, Diageo, British American Tobacco, GSK, Glencore and Rio Tinto.

BetaShares says that the ASX ETF's distribution yield, which is based on the last 12 months of distributions, is around 3%. That's not huge, but it's more than double the dividend yield of the US shares-focused iShares S&P 500 ETF.

The ETF is delivering capital growth, though we can never know when volatility may hit. As we can see on the graph below, the Betashares FTSE 100 ETF has risen by over 11% in 2023 to date.

Australian Ex-20 Portfolio Diversifier ETF (ASX: EX20)

As the name suggests, this ASX ETF is invested in ASX shares, but a key difference to ones like the VAS ETF is that it excludes the biggest 20 ASX shares and invests in the next 180 names. In other words, it's not invested in names like Commonwealth Bank of Australia (ASX: CBA), BHP Group Ltd (ASX: BHP) and CSL Limited (ASX: CSL).

What are the benefits of this? Firstly, the EX20 ETF reduces portfolio concentration to a few large banks and miners – it can enable diversification.

With this 180-name portfolio, I think it can deliver a bit more growth. Larger businesses are normally quite far along on their growth journey, whereas the smaller ones could have more growth potential.

As of 18 May 2023, these were the biggest 10 positions: Brambles Limited (ASX: BXB), South32 Ltd (ASX: S32), James Hardie Industries plc (ASX: JHX), Sonic Healthcare Ltd (ASX: SHL), Cochlear Limited (ASX: COH), Suncorp Group Ltd (ASX: SUN), Northern Star Resources Ltd (ASX: NST), Origin Energy Ltd (ASX: ORG),  Scentre Group (ASX: SCG) and ResMed Inc (ASX: RMD).

Seeing as this article is about passive income, now let's look at the most important part of the ASX ETF – the dividend yield. BetaShares said that the last 12 month distribution yield is 3.1% or 3.8% when grossed up for franking credits.

If the underlying EX20 ETF's businesses can achieve attractive earnings growth over time, then it could mean that the dividends could grow at a faster pace.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Cochlear, and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Cochlear, Sonic Healthcare, and iShares S&P 500 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ETFs

Kid putting a coin in a piggy bank.
ETFs

Why this could be a great time to buy this high-performing ASX ETF

In my view, this is one of the most compelling ETFs Aussies can buy.

Read more »

Cubes placed on a Notebook with the letters "ETF" which stands for "Exchange traded funds".
ETFs

Up 32%: Can the BetaShares Nasdaq 100 ETF (NDQ) do it again in 2025?

It would take a lot for this extraordinary ETF to pull another stunner out of its hat next year.

Read more »

A beautiful ocean vista is shown with a woman whose back is to the camera holding her arms up in triumph as she stands at the top of a rock feeling thrilled that ASX 200 shares are reaching multi-year high prices today
ETFs

3 unstoppable ASX ETFs smashing new record highs today

Index-based ASX ETFs tracking the Australian and overseas markets are having an exceptional run in 2024.

Read more »

ETF written in yellow gold.
ETFs

3 quality ASX ETFs for Aussie investors in December

Here's why these funds could be great options for investors this month and beyond.

Read more »

Two people comparing and analysing material.
ETFs

Should I invest in the Vanguard Australian Shares Index ETF (VAS) or a term deposit?

Is the ASX share market or a term deposit a better buy for Aussies?

Read more »

Ten smiling business people wave to the camera after receiving some winning company news.
ETFs

Vanguard Australian Shares Index ETF has lifted 20% in a year. Which stocks have contributed most to its rise?

This popular ASX ETF seeks to track the performance of the S&P/ASX 300 Index before fees.

Read more »

The letters ETF sit in orange on top of a chart with a magnifying glass held over the top of it
Technology Shares

What happened to Betashares Nasdaq 100 ETF (NDQ) in November?

One big factor led to a 7.35% run for this popular US tech-heavy exchange-traded fund during the month.

Read more »

Woman looks amazed and shocked as she looks at her laptop.
ETFs

This unstoppable ASX ETF soared 5,900% over the past 10 years. Here's how it could turn $250,000 into $1 million over the next decade (or less)

This fund has achieved excellent performance. It could keep delivering.

Read more »